| ²é¿´: 1382 | »Ø¸´: 7 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
chgj2000
|
[½»Á÷]
¡¾ÇóÖú¡¿ÇóÉ걨×ÊÁÏ
|
||
| FeridexÄܰïÎÒ²éÏÂËüµÄÉ걨×ÊÁÏÂð£¨FDA£© |
» ²ÂÄãϲ»¶
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ294È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ1È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÇóÖúµç×Ӱ棺¾§ÐÍÒ©ÎïÑз¢ÀíÂÛÓëÓ¦ÓÃ
ÒѾÓÐ0È˻ظ´
±±¾©´óѧҩѧԺ³ÏÕÐÒ©Îﻯѧ/Óлú»¯Ñ§·½Ïò²©Ê¿ºó
ÒѾÓÐ5È˻ظ´
2026ÉúÎïÒ½Ò©²úÒµ·¢Õ¹´ó»á
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖúÒ»¸ö¹ØÓÚÉêÇë²ÄÁϵÄС°×ÎÊÌâ
ÒѾÓÐ6È˻ظ´
ÇóÖúH4ÉêÇë²ÄÁÏ£¨¸øÃÀ¹úÃØÊ飩
ÒѾÓÐ3È˻ظ´
Ò©ÀíÉ걨×ÊÁÏÇóÖú
ÒѾÓÐ9È˻ظ´
[ÇóÖú]ÉêÇ빫ÅɶÁ²©ºÏ×÷ÏîÄ¿µÄͬѧÊÇ·ñÐèÒªÌá½»ÉêÇëѧУʱµÄÔ²ÄÁÏ£¿
ÒѾÓÐ24È˻ظ´
¡¾ÇóÖú¡¿¹ØÓÚÉêÇë²ÄÁϵļ±ÎÊ
ÒѾÓÐ36È˻ظ´
¡¾ÇóÖú¡¿ÎÒµÄÉêÇë²ÄÁÏÉϽ»Ê±£¬10¸ö·½¿òµÄѧºÅ¶¼ÊǿյÄ
ÒѾÓÐ9È˻ظ´
¡¾Ô´´¡¿6Àà·ÂÖÆÒ©É걨ÏîÄ¿¼°×ÊÁÏÒªÇó
ÒѾÓÐ902È˻ظ´
¡¾ÇóÖú¡¿AC2993Ò»ÆÚ¡¢¶þÆÚÁÙ´²Ñо¿É걨×ÊÁÏ
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿ÉêÇë·¨¹úÁôѧ-ÐèÒª·¨·½ÌṩÄÄЩ²ÄÁÏ
ÒѾÓÐ3È˻ظ´
¡¾ÇóÖú¡¿Ò©Æ·É걨·¢²¹×ÊÁÏ
ÒѾÓÐ12È˻ظ´
¡¾ÇóÖú¡¿ËÓÐÒ©Æ·×¢²áÉ걨21¡¢22¡¢25¡¢26ºÅ×ÊÁÏ£¿£¿ÎÒÃÇ×ö×÷Òµ¼±Ðèѽ£¡£¡£¡£¡
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú¡¿ÐÂÒ©É걨µÄÔʼ¼Ç¼×ÊÁÏÈçºÎд£¿£¿
ÒѾÓÐ19È˻ظ´
¡¾ÇóÖú¡¿ÇóÖú£¡20¸ö½ð±ÒÇóÐÂÒ©É걨µÄ13ºÅ×ÊÁÏÄ£°å
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿¹ØÓÚÉêÇë²ÄÁÏÖеġ°Ö÷Òª¿ÆÑгɹû£¨Çåµ¥¼°ÕªÒª£©¡±
ÒѾÓÐ22È˻ظ´
¡¾ÇóÖú¡¿ÔÁÏÒ©É걨×ÊÁÏ 8ºÅ ×ÊÁϵÄÒÉ»ó
ÒѾÓÐ19È˻ظ´
chgj2000
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3.5
- É¢½ð: 33
- Ìû×Ó: 186
- ÔÚÏß: 19.3Сʱ
- ³æºÅ: 357445
- ×¢²á: 2007-04-27
- ÐÔ±ð: GG
- רҵ: ´Å¹²Õñ³ÉÏñ¼¼ÊõÓëÔìÓ°¼Á
3Â¥2010-11-04 11:18:25
ronalbeck
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 454.5
- É¢½ð: 100
- ºì»¨: 4
- Ìû×Ó: 519
- ÔÚÏß: 92.8Сʱ
- ³æºÅ: 795346
- ×¢²á: 2009-06-16
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
chgj2000(½ð±Ò+1):лл£¡ 2010-11-03 09:53:14
|
Drug Details Drug Name(s) FERIDEX I.V. (Brand Name Drug) FDA Application No. (NDA) 020416 Active Ingredient(s) FERUMOXIDES Company AMAG PHARMS INC Original Approval or Tentative Approval Date August 30, 1996 Chemical Type 1 New molecular entity (NME) Review Classification S Standard review drug There are no Therapeutic Equivalents Labels are not available Approval History, Letters, Reviews, and Related Documents Products on Application (NDA) #020416 Click on a column header to re-sort the table: Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code FERIDEX I.V. FERUMOXIDES EQ 11.2MG IRON/ML INJECTABLE; INJECTION Prescription Yes None Õâ¸öҩûÓÐ˵Ã÷Êé°¡£¡ Label Information What information does a label include? Note: Not all labels are available in electronic format from FDA. Labels are not available on this site for FERIDEX I.V., NDA no. 020416 Approval History NDA 020416 Note: Not all reviews are available in electronic format from FDA. Older labels are for historical information only, and should not be used for clinical purposes. Approval dates can only be verified from 1984 to the present. Click on a column header to re-sort the table: Action Date Supplement Number Approval Type Letters, Reviews, Labels, Patient Package Insert Note 10/11/1996 001 Labeling Revision Label is not available on this site. 08/30/1996 000 Approval Label is not available on this site. Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players There are no Therapeutic Equivalents |
2Â¥2010-11-03 08:44:59
iamzane
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 129 (¸ßÖÐÉú)
- ¹ó±ö: 0.7
- ½ð±Ò: 24851.6
- É¢½ð: 40
- ºì»¨: 21
- Ìû×Ó: 1978
- ÔÚÏß: 460.6Сʱ
- ³æºÅ: 330866
- ×¢²á: 2007-03-24
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
chgj2000(½ð±Ò+1): 2011-01-07 11:29:04
|
http://www.amagpharma.com/products/feridex_iv.php In November 2008, the Company ceased manufacturing of Feridex and does not intend to continue its commercialization. The Company has terminated agreements with all of our Feridex marketing partners including Bayer Healthcare Pharmaceuticals and TaeJoon Pharmaceuticals Co., Ltd. È˼Ҷ¼²»ÂôÁ˰¡¡£ |
4Â¥2011-01-07 09:10:31
chgj2000
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3.5
- É¢½ð: 33
- Ìû×Ó: 186
- ÔÚÏß: 19.3Сʱ
- ³æºÅ: 357445
- ×¢²á: 2007-04-27
- ÐÔ±ð: GG
- רҵ: ´Å¹²Õñ³ÉÏñ¼¼ÊõÓëÔìÓ°¼Á
5Â¥2011-01-07 11:31:04









»Ø¸´´ËÂ¥
20